Assess Rights, Safety and Well-Being
Evaluate informed consent, eligibility, safety reporting, medical oversight and the controls used to protect trial participants.
Back to Inspection & Audit
Good Clinical Practice Auditing
GCP Audits
Independent, risk-based GCP audits for sponsors, CROs, investigator sites, vendors and research organizations seeking stronger participant protection, reliable clinical data, effective oversight and inspection-ready trial conduct.
Service Overview
Independent Assurance Across the Clinical Trial Lifecycle
GCP audits are designed to assess whether trial activities are planned, conducted, documented and overseen in a manner that protects participants and supports reliable, reconstructable clinical data.
Confirm Traceability and Accuracy
Review source records, case report forms, clinical systems and essential documentation to determine whether trial data is complete, consistent and attributable.
Evaluate Governance and Control
Assess whether sponsor, CRO and vendor responsibilities are clearly defined, monitored, escalated and supported by documented oversight.
Common Clinical Compliance Risks
Where Clinical Trials Commonly Lose Control
GCP weaknesses often arise where responsibilities are fragmented, documentation does not reflect practice or oversight fails to identify and escalate important trial risks.
Informed Consent Weaknesses
Consent processes, signatures, dates, approved versions or re-consenting practices do not fully demonstrate participant understanding and regulatory compliance.
Protocol Noncompliance
Eligibility, procedures, visit windows, investigational product handling or safety requirements are not followed consistently.
Insufficient Sponsor Oversight
Vendor performance, monitoring issues, quality signals and recurring deviations are not escalated or managed through a controlled oversight process.
Unreliable Clinical Evidence
Source records, eCRF data, essential documents and system records do not provide a complete and reconstructable account of trial conduct.
GCP Audit Types
Flexible Audit Scope Based on Trial Risk
GCP audits can be focused on one site, vendor, process or system, or delivered as part of a broader clinical quality assurance program.
Investigator Site Audits
Independent assessment of site-level trial conduct, participant protection, protocol compliance and clinical data reliability.
- Investigator oversight and delegation
- Informed consent process
- Eligibility and protocol compliance
- Source records and data traceability
- Safety reporting and investigational product control
Sponsor Audits
Evaluation of sponsor governance, clinical quality systems, risk management, oversight and inspection preparedness.
- Clinical quality management system
- Vendor and CRO oversight
- Risk-based quality management
- Issue escalation and CAPA
- Management review and quality metrics
CRO Audits
Independent review of delegated clinical activities, operational controls, escalation practices and sponsor-facing oversight evidence.
- Monitoring and clinical operations
- Project governance and escalation
- Data management and safety interfaces
- Staff qualification and training
- Quality system and CAPA effectiveness
Clinical Process Audits
Focused assessment of specific processes that carry significant participant, data or inspection risk.
- Monitoring and site management
- Safety reporting processes
- Clinical data management
- Protocol deviation management
- Essential document and TMF processes
Vendor and Service Provider Audits
Qualification and oversight audits for laboratories, imaging vendors, eClinical providers and other critical clinical trial partners.
- Vendor qualification readiness
- Quality agreements and responsibilities
- Operational and system controls
- Data transfer and issue management
- Performance monitoring and escalation
For-Cause GCP Audits
Focused independent assessment when serious concerns, recurring deviations or potential systemic failures require urgent review.
- Serious protocol noncompliance
- Participant safety concerns
- Data integrity concerns
- Repeat monitoring or audit findings
- Independent investigation support
Audit Scope
Areas Commonly Evaluated During a GCP Audit
The audit scope is defined according to the trial, organization, delegated responsibilities, known risks and intended business outcome.
Participant Protection
- Informed consent documentation
- Subject eligibility
- Medical oversight
- Safety reporting
- Protection of vulnerable populations
Protocol Compliance
- Protocol adherence
- Visit and procedure compliance
- Deviation identification
- Deviation escalation
- Corrective action effectiveness
Clinical Data Integrity
- Source data verification
- eCRF and source consistency
- Data corrections and traceability
- Electronic record controls
- ALCOA+ expectations
Investigational Product
- Receipt and accountability
- Storage conditions
- Dispensing and return
- Temperature excursions
- Reconciliation and destruction
Sponsor and CRO Oversight
- Delegated responsibility control
- Quality agreement clarity
- Vendor performance monitoring
- Escalation and decision-making
- Oversight documentation
Quality System Effectiveness
- SOP implementation
- Training and qualification
- Deviation and CAPA systems
- Quality metrics and management review
- Inspection readiness
Audit Process
A Structured GCP Audit From Planning to Follow-Up
The process is designed to produce objective findings, clear risk classification and practical recommendations that support meaningful corrective action.
Audit Context Review
Understand the protocol, trial phase, sites, vendors, systems, delegated responsibilities and known quality risks.
Risk-Based Planning
Define objectives, criteria, documentation needs, interviewees, sampling strategy and areas requiring deeper assessment.
Pre-Audit Document Review
Review relevant procedures, plans, reports, quality records, trial documents and available performance information.
Audit Execution
Conduct interviews, process walkthroughs, system demonstrations, document review and evidence-based sampling.
Finding Evaluation
Assess the significance, recurrence, systemic nature and potential impact of identified compliance weaknesses.
Reporting and Follow-Up
Deliver findings, recommendations and optional CAPA review or effectiveness verification support.
Deliverables
Clear Outputs for Clinical, QA and Leadership Teams
Deliverables are tailored to the audit type, business purpose, contractual requirements and level of executive visibility required.
Audit Plan
- Audit objectives and scope
- Applicable criteria
- Functions and processes included
- Document request list
- Interview and audit schedule
Audit Report
- Executive summary
- Evidence-based observations
- Risk classification
- Systemic and recurring themes
- Recommended next steps
Leadership Risk Summary
- Material compliance concerns
- Participant and data risks
- Oversight weaknesses
- Inspection exposure considerations
- Priority decisions and escalation points
CAPA Review Support
- Root cause challenge
- Action adequacy review
- Risk reduction assessment
- Evidence expectations
- Closure readiness considerations
Follow-Up Audit
- CAPA implementation review
- Evidence verification
- Repeat finding assessment
- Residual risk review
- Effectiveness verification
Audit Program Insights
- Cross-audit trends
- Recurring quality themes
- Vendor or site risk signals
- Program maturity observations
- Future audit priorities
When GCP Audits Are Most Valuable
Common Clinical Audit Scenarios
GCP audits can support routine quality assurance, vendor governance, inspection preparation or urgent investigation of serious concerns.
Site Qualification
A high-enrolling or high-risk investigator site requires independent assessment before or during trial participation.
Vendor Qualification
A CRO or clinical service provider must be evaluated before selection or contract renewal.
Inspection Preparation
A sponsor, CRO or site needs independent assurance before regulatory inspection.
Recurring Deviations
Similar deviations across sites or studies indicate a possible systemic process weakness.
Participant Safety Concern
Safety reporting, medical oversight or protocol compliance requires urgent independent review.
Data Integrity Concern
Source records, electronic data or trial documentation raise questions about reliability and traceability.
New Sponsor or Program
A growing organization requires an independent assessment of its clinical quality system and oversight model.
Transaction Due Diligence
A clinical asset, partner or acquisition target requires quality and compliance risk assessment.
Business Value
Protect Participants, Data and Clinical Development Decisions
Independent GCP audits help organizations identify clinical risk earlier, improve oversight and demonstrate that trial activities are controlled and supported by reliable evidence.
Stronger Participant Protection
Identify weaknesses in consent, eligibility, safety reporting and medical oversight before they create significant regulatory exposure.
More Reliable Clinical Data
Improve confidence that trial data is attributable, complete, consistent and reconstructable.
More Effective Oversight
Strengthen sponsor, CRO and vendor governance through clearer responsibilities, escalation and performance visibility.
FAQ
GCP Audit Questions
Common questions from sponsors, CROs, clinical vendors and research organizations considering independent GCP audit support.
Can you conduct remote GCP audits?
Yes. Depending on the scope, systems and available documentation, investigator site, sponsor, CRO, vendor and process audits can be delivered remotely, onsite or through a hybrid model.
Can a GCP audit focus on one specific clinical process?
Yes. The audit can focus on monitoring, informed consent, safety reporting, data management, protocol deviations, vendor oversight, TMF management or another defined clinical process.
Can you audit against ICH GCP E6(R3)?
Yes. The audit scope can incorporate applicable ICH GCP E6(R3) principles, risk-proportionate quality management and expectations relating to sponsor and investigator responsibilities.
Can you support CAPA development after the audit?
Yes. Support can include root cause review, CAPA adequacy assessment, remediation planning and follow-up effectiveness verification.
Can you conduct confidential for-cause audits?
Yes. Focused and for-cause audits can be conducted confidentially when serious compliance, participant safety or data integrity concerns require independent review.
Is NDA-based collaboration available?
Yes. GCP audit engagements are handled confidentially, and NDA-based collaboration can be used where required.